Borrelia burgdorferi Antigens

This panel is designed to detect Lyme disease. It combines the Lyme Dot Blot (3 samples) and Lyme Multiplex PCR Urine (pooled) tests. This test is unavailable for patients over 65 when ordered through physician services.

Lyme Dot Blot Assay (LDA) is a qualitative immunoassay for the direct detection of Borrelia burgdorferi–specific antigens in a patient's urine sample using anti–B. burgdorferi antibodies. This test is unavailable for patients over 65 when ordered through physician services.

Lyme Dot Blot Assay (LDA) is a qualitative immunoassay for the direct detection of Borrelia burgdorferi–specific antigens in a patient's urine sample using anti–B. burgdorferi antibodies. This test is unavailable for patients over 65 when ordered through physician services.

Lyme Dot Blot Assay (LDA) is a qualitative immunoassay for the direct detection of Borrelia burgdorferi–specific antigens in a patient's urine sample using anti–B. burgdorferi antibodies. This test is unavailable for patients over 65 when ordered through physician services.